Immix Biopharma, Inc. (IMMX) NASDAQ
8.37
-0.855(-9.27%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 172.41M |
| Enterprise Value | 79.56M |
| P/E Ratio | -9.15 |
| PEG Ratio | 0.36 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.8 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -10.59 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.37 |
| Return On Equity | -0.73 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -364,501 |
| EBITDA | -26.85M |
| Net Income | -29.44M |
| Diluted EPS | -0.89 |
Balance Sheet
| Total Cash | 90.58M |
| Total Cash/Share | 2.37 |
| Total Debt | 1.04M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 8.76 |
| Book Value Per Share | 2.2 |
Price History
| 52-Week Change | 221.73 |
| 52-Week High | 11.61 |
| 52-Week Low | 1.87 |
| Moving Average 50 Days | 9.33 |
| Moving Average 200 Days | 5.89 |
Statistics
| Average Volume | 960,711 |
| Shares Outstanding | 54.41M |
| % Held by Institutions | 70.72 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
